donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > BCPC Balchem > Key Indicators
BCPC Balchem
126.600
+5.270+4.34%
Post Mkt Price
125.990
-0.61-0.48%
YOY
Do not show
Hide blank lines
(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31(Q3)2021/09/30
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
-7.89% 85.4615 -10.8% 76.0709 -10.8% 76.0709 -3.44% 83.5863
Receivable Turnover(T)
2.78% 6.9098 0.93% 7.4113 0.93% 7.4113 2.31% 7.3212
Inventory Turnover(T)
3.89% 6.3234 10.73% 6.876 10.73% 6.876 7.62% 6.6603
Fixed Assets Turnover(T)
11.15% 3.4742 8.24% 3.3065 8.24% 3.3065 3.65% 3.2844
Total Asset Rate(T)
16.18% 0.7125 11.46% 0.6757 11.46% 0.6757 7.26% 0.655
ROIC
14.42% 10.217% 11.41% 9.822% 11.41% 9.822% 7.31% 9.411%
ROE
7.96% 11.795% 4.69% 11.272% 4.69% 11.272% 2.39% 10.924%
ROA
13.54% 8.597% 11.47% 8.127% 11.47% 8.127% 8.66% 7.974%
FCF to Sales
-45.74% 10.156% -7.11% 15.402% -7.11% 15.402% 6.64% 16.738%
FCF to Net Income
-44.47% 84.169% -7.12% 128.054% -7.12% 128.054% 5.27% 137.499%
Efficiency Ratios
ROE 5 Year Average
-- -- -0.16% 12.196% -- -- -- --
ROA 5 Year Average
-- -- 5.24% 8.075% -- -- -- --
Average 5 Years ROIC
-- -- 4.27% 9.921% -- -- -- --
Profitability Ratios TTM
Gross Margin
-4.42% 30.390% -4.35% 30.434% -4.35% 30.434% -4.17% 30.776%
Operating Margin
-0.55% 16.060% 1.02% 15.957% 1.02% 15.957% 4.16% 15.993%
Net Margin
-2.28% 12.066% 0.01% 12.028% 0.01% 12.028% 1.31% 12.173%
EBITDA Margin
-6.39% 0.218% -4.1% 0.221% -4.1% 0.221% -0.78% 0.2249%
R & D Expense Ratio
14.48% 1.660% 14.97% 1.690% 14.97% 1.690% -7.59% 1.460%
Sales Expense Ratio
-8.73% 7.420% -9.24% 7.560% -9.24% 7.560% -8.8% 7.880%
Administration Expense Rate
-13.37% 5.250% -16.08% 5.220% -16.08% 5.220% -16.67% 5.450%
Financial Health Ratios
Long-Term Debt to Equity Ratio
-17.62% 15.516% -35.6% 13.191% -35.6% 13.191% -46.64% 12.998%
Total Assets to Common Equity
-0.63% 136.767% -2.85% 136.751% -2.85% 136.751% -6.4% 132.648%
Debt to Asset Ratio
-17.36% 15.786% -35.18% 13.460% -35.18% 13.460% -46.02% 13.272%
Current Ratio
-18.28% 2.5889 -20.72% 2.2408 -20.72% 2.2408 -27.52% 2.8618
Quick Ratio
-25.9% 1.6307 -20.73% 1.5344 -20.73% 1.5344 -26.34% 1.913
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- 29.68% 7.472% -- -- -- --
Revenue CAGR(5Y)
-- -- 53.98% 7.630% -- -- -- --
Net Income CAGR(3Y)
-- -- 437.36% 6.944% -- -- -- --
Net Income CAGR(5Y)
-- -- 58.17% 11.418% -- -- -- --
Dividend CAGR(3Y)
-- -- -4.58% 10.839% -- -- -- --
Dividend CAGR(5Y)
-- -- -2.52% 10.989% -- -- -- --
FCF 1 Year Growth
-- -- -74.45% 5.485% -- -- -- --
FCF CAGR(3Y)
-- -- -38.48% 7.532% -- -- -- --
FCF CAGR(5Y)
-- -- -41.15% 8.036% -- -- -- --
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
CEO: Harris, Theodore L.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...